Islay Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Islay Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.6K	Hold	630	–	–	0.03%	124
2025 Q4	$53.4K	Hold	630	–	–	0.03%	116
2025 Q3	$45.7K	Hold	630	–	–	0.03%	136
2025 Q2	$41.3K	Hold	630	–	–	0.03%	127
2025 Q1	$44.5K	Hold	630	–	–	0.03%	120
2024 Q4	$41.4K	Hold	630	–	–	0.03%	130
2024 Q3	$44.5K	Hold	630	–	–	0.03%	127
2024 Q2	$41.8K	Hold	630	–	–	0.03%	132
2024 Q1	$42.8K	Hold	630	–	–	0.03%	131
2023 Q4	$38.9K	Hold	630	–	–	0.03%	141
2023 Q3	$37.2K	Hold	630	–	–	0.03%	140
2023 Q2	$37.6K	Hold	630	–	–	0.03%	136
2023 Q1	$36.8K	Hold	630	–	–	0.04%	142
2022 Q4	$39.1K	Hold	630	–	–	0.04%	143
2022 Q3	$36K	Hold	630	–	–	0.04%	159
2022 Q2	$40K	Hold	630	–	–	0.04%	191
2022 Q1	$41K	Hold	630	–	–	0.03%	201
2021 Q4	$42K	Hold	630	–	–	0.03%	191
2021 Q3	$38K	Hold	630	–	–	0.03%	209
2021 Q2	$39K	Hold	630	–	–	0.03%	207
2021 Q1	$37K	Hold	630	–	–	0.03%	188
2020 Q4	$38K	Hold	630	–	–	0.03%	189
2020 Q3	$34K	Hold	630	–	–	0.04%	189
2020 Q2	$32K	Hold	630	–	–	0.04%	186
2020 Q1	$28K	Buy	+630	New	+$31.8K	0.04%	174

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Islay Capital Management's IHE Position: Q1 2026 in Review

Islay Capital Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 630 shares worth $54.6K. The position accounts for 0.03% of the portfolio, ranked #124.

Islay Capital Management first reported a position in IHE in Q1 2020 and has held it in 25 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Islay Capital Management held 630 shares of iShares US Pharmaceuticals ETF worth $54.6K as of Q1 2026.
Islay Capital Management left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
iShares US Pharmaceuticals ETF made up 0.03% of Islay Capital Management's portfolio in Q1 2026, its #124 holding.
Islay Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2020 and has held it in 25 quarters since.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Islay Capital Management's 13F filing for Q1 2026, filed 14 May 2026.